These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 5951461)

  • 1. [Experimental study on age differentiation in the nephrotic syndrome induced by aminonucleoside. II. Effect of cortisone].
    Okada T
    Nihon Shonika Gakkai Zasshi; 1966 Jun; 70(6):531-8. PubMed ID: 5951461
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental study on age differentiation in the nephrotic syndrome induced by aminonucleoside. I].
    Okada T
    Nihon Shonika Gakkai Zasshi; 1966 Jun; 70(6):517-30. PubMed ID: 5951460
    [No Abstract]   [Full Text] [Related]  

  • 3. Aminonucleoside nephropathy. An experimental study.
    Mathur KS; Wahal PK; Singh KK
    J Assoc Physicians India; 1968 Jan; 16(1):1-8. PubMed ID: 5655058
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic basis of aminonucleoside nephrosis in rats. II. Inhibition of renal gluconeogenesis by aminonucleoside.
    Yoshida T; Metcoff J
    J Lab Clin Med; 1968 Oct; 72(4):576-81. PubMed ID: 5677305
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of aminonucleoside on the kidney of fetuses].
    Masshoff W; Köhler E; Stolpmann HJ
    Frankf Z Pathol; 1966; 75(2):100-14. PubMed ID: 6011704
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic basis of aminonucleoside nephrosis in rats. I. Inhibition of alpha-oxoglutarate oxidation by aminonucleoside.
    Yoshida T; Yamashita F; Metcoff J
    J Lab Clin Med; 1968 Oct; 72(4):565-75. PubMed ID: 4300304
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indomethacin in the treatment of nephrotic syndrome induced with aminonucleoside].
    Sessa A; Conte F; Cioffi A
    Minerva Nefrol; 1975; 22(6):291-8. PubMed ID: 1223707
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental study on age differentiation in nephrosis induced by aminonucleosides. 3. Long-term observations on its transitional process to chronic nephrosis].
    Okada T
    Nihon Shonika Gakkai Zasshi; 1966 Jul; 70(7):589-600. PubMed ID: 6005802
    [No Abstract]   [Full Text] [Related]  

  • 9. Morphometry of the glomeruli in puromycin aminonucleoside nephrotic syndrome.
    Pinto JA; Brewer DB
    J Pathol; 1973 Jan; 109(1):Pxi. PubMed ID: 4719760
    [No Abstract]   [Full Text] [Related]  

  • 10. [Proceedings: Focal glomerular lesions in the late stage of aminonucleoside nephrosis (ANN) in rats].
    Schöll A; Hiller GW; Gärtner HV
    Verh Dtsch Ges Pathol; 1974; 58():483. PubMed ID: 4460511
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology of experimental nephrotic syndrome induced by puromicyn aminonucleoside in rats. III. Effect of captopril, an angiotensin converting enzyme inhibitor, on proteinuria and sodium retention.
    Pedraza-Chaverrí J; Cruz C; Chávez MT; Ibarra-Rubio ME; Tapia E; Peña JC
    Rev Invest Clin; 1990; 42(3):210-6. PubMed ID: 2270368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Courses of coagulation-fibrinolysis system and renal histological findings in aminonucleoside nephrosis (author's transl)].
    Kikuchi K
    Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1087-104. PubMed ID: 7321318
    [No Abstract]   [Full Text] [Related]  

  • 13. Scanning electron microscopy of aminonucleoside nephrosis.
    Carroll N; Crock GW; Funder CC; Green CR; Ham KN; Tange JD
    J Pathol; 1973 Sep; 111(1):37-42. PubMed ID: 4757509
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. II. In vitro release of renin, angiotensinogen and aldosterone.
    Pedraza-Chaverrí J; Cruz C; Chávez MT; López A; Ibarra-Rubio ME; Tapia E; Peña JC
    Rev Invest Clin; 1990; 42(2):120-6. PubMed ID: 2267444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of antithrombin on puromycin aminonucleoside nephrosis in rats.
    Yamashita J; Nakajima K; Ohno Y; Kaneshiro Y; Matsuo T; Tanaka H; Kaneko K
    Eur J Pharmacol; 2008 Jul; 589(1-3):239-44. PubMed ID: 18541230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of aminonucleoside nephrosis in rats. IV. Prevention by N6-methyladenosine.
    Derr RF; Loechler DK; Alexander CS; Nagasawa HT
    J Lab Clin Med; 1968 Sep; 72(3):363-9. PubMed ID: 5674067
    [No Abstract]   [Full Text] [Related]  

  • 17. The fibrinolytic enzyme system of the rat: the effect of aminonucleoside-induced nephrotic syndrome.
    Marsh NA
    Br J Exp Pathol; 1969 Feb; 50(1):1-12. PubMed ID: 5773142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired primary antibody response in experimental nephrotic syndrome.
    Garin EH; Sausville PJ; Richard GA
    Clin Exp Immunol; 1983 Jun; 52(3):595-8. PubMed ID: 6347472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cortisone on plasma lipids in the course of experimental aminonucleoside-induced nephrosis in the rat. 3].
    CENCIOTTI L; MARIOTTI A
    Riv Anat Patol Oncol; 1961 Oct; 20():498-502. PubMed ID: 13877649
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.